Clinical Trial Update: A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks [NA]

View source ↗

Summary

A randomized controlled trial comparing topical tacrolimus 0.03% with crisaborole 2% for mild to moderate atopic dermatitis over 8 weeks; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Crisaborole 2% (topical) (Crisaborole)
• Tacrolimus 0.03% (topical) (Tacrolimus)

Snippet

Sponsor: Foundation University Islamabad | Conditions: Atopic Dermatitis | NA | Status: NOT_YET_RECRUITING